Abstract

42 patients suffered from benign prostatic hyperplasia were treated with laser assisted TUR-P. Their results were studied comparatively with 56 other patients belonging to a group treated with VLAP only. Compared with the VLAP mono-therapy group, the laser assisted TUR-P group showed significant improvement in every parameter both one month and three months post-operatively. Especially, the patients on the laser assisted TUR-P therapy were notably improved in MFR, in post-void residual urine and in estimated prostate weight, one month after treatment, proving this therapy to be faster and more radical. Their estimated bleedings were significantly less than those of the 30 patients composing a TUR-P mono-therapy group. They required no transfusion and noticed no other serious complications. The laser assisted TUR-P is an efficient therapy that combines VLAP with TUR-P, making full use of their advantages and having their disadvantages made up for by each other.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call